HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michela Dal Pos Selected Research

Liraglutide

3/2015Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
12/2013Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michela Dal Pos Research Topics

Disease

2Weight Loss (Weight Reduction)
03/2015 - 12/2013
1Type 2 Diabetes Mellitus (MODY)
03/2015

Drug/Important Bio-Agent (IBA)

2LiraglutideFDA Link
03/2015 - 12/2013
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
03/2015
1Insulin (Novolin)FDA Link
03/2015
1LipidsIBA
03/2015
1Metformin (Glucophage)FDA LinkGeneric
03/2015

Therapy/Procedure

1Therapeutics
03/2015